Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $75.5B | $104.6B | $105.6B | $92.1B | $96.2B | |
| Revenue Growth (YoY) | -3.21% | 38.53% | 0.9% | -12.71% | 4.37% | |
| Cost of Revenues | $68.5B | $95B | $95.6B | $83.5B | $88.3B | |
| Gross Profit | $7.1B | $9.6B | $9.9B | $8.6B | $7.9B | |
| Gross Profit Margin | 9.37% | 9.21% | 9.41% | 9.36% | 8.24% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.6B | $5.2B | $5.1B | $5.4B | $5.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $5.4B | $5B | $4.9B | $5.1B | $5.4B | |
| Operating Income | $1.7B | $4.6B | $5B | $3.5B | $2.5B | |
| Net Interest Expenses | $483.3M | $403.5M | $844.7M | $1.1B | $1.1B | |
| EBT. Incl. Unusual Items | $2.1B | $6.5B | $6.2B | $5.6B | $4.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $941.2M | $2B | $1.8B | $1.5B | $1.4B | |
| Net Income to Company | $3.3B | $8.3B | $8.5B | $7.5B | $6B | |
| Minority Interest in Earnings | $140.7M | $204.2M | $177.1M | $116.1M | $139.2M | |
| Net Income to Common Excl Extra Items | $3.3B | $8.3B | $8.5B | $7.5B | $6B | |
| Basic EPS (Cont. Ops) | $0.94 | $2.50 | $2.66 | $2.44 | $2.01 | |
| Diluted EPS (Cont. Ops) | $0.94 | $2.50 | $2.66 | $2.44 | $2.01 | |
| Weighted Average Basic Share | $3.4B | $3.3B | $3.1B | $3B | $2.9B | |
| Weighted Average Diluted Share | $3.4B | $3.3B | $3.1B | $3B | $2.9B | |
| EBITDA | $4.3B | $7.3B | $7.1B | $5.6B | $4.6B | |
| EBIT | $1.7B | $4.6B | $5B | $3.5B | $2.5B | |
| Revenue (Reported) | $75.5B | $104.6B | $105.6B | $92.1B | $96.2B | |
| Operating Income (Reported) | $1.7B | $4.6B | $5B | $3.5B | $2.5B | |
| Operating Income (Adjusted) | $1.7B | $4.6B | $5B | $3.5B | $2.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $25.1B | $26.8B | $22.3B | $23.4B | $23.5B | |
| Revenue Growth (YoY) | 43% | 6.85% | -16.58% | 4.78% | 0.25% | |
| Cost of Revenues | $22.7B | $24.5B | $20.2B | $21.5B | $21.3B | |
| Gross Profit | $2.4B | $2.3B | $2.1B | $1.9B | $2.2B | |
| Gross Profit Margin | 9.4% | 8.6% | 9.53% | 8.01% | 9.18% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.2B | $1.4B | $1.6B | $1.5B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.3B | $1.2B | $1.4B | $1.6B | $1.5B | |
| Operating Income | $1.1B | $1.1B | $692.7M | $266.6M | $688.3M | |
| Net Interest Expenses | $103.9M | $168.1M | $290M | $264.1M | $329.3M | |
| EBT. Incl. Unusual Items | $1.6B | $1.4B | $1.2B | $439.6M | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $608.2M | $521.8M | $494.2M | $322.8M | $497.2M | |
| Net Income to Company | $2B | $1.9B | $1.5B | $927.4M | $1.6B | |
| Minority Interest in Earnings | $37.6M | $25.8M | $49.9M | $18.2M | $47.7M | |
| Net Income to Common Excl Extra Items | $2B | $1.9B | $1.5B | $927.4M | $1.6B | |
| Basic EPS (Cont. Ops) | $0.59 | $0.60 | $0.47 | $0.31 | $0.55 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.60 | $0.47 | $0.31 | $0.55 | |
| Weighted Average Basic Share | $3.3B | $3.2B | $3B | $2.9B | $2.9B | |
| Weighted Average Diluted Share | $3.3B | $3.2B | $3B | $2.9B | -- | |
| EBITDA | $1.7B | $1.6B | $1.2B | $789.1M | $1.2B | |
| EBIT | $1.1B | $1.1B | $692.7M | $266.6M | $688.3M | |
| Revenue (Reported) | $25.1B | $26.8B | $22.3B | $23.4B | $23.5B | |
| Operating Income (Reported) | $1.1B | $1.1B | $692.7M | $266.6M | $688.3M | |
| Operating Income (Adjusted) | $1.1B | $1.1B | $692.7M | $266.6M | $688.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $100B | $110.6B | $95.5B | $94.9B | $94.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $91B | $100.5B | $85.6B | $86.1B | $85.7B | |
| Gross Profit | $9B | $10B | $9.9B | $8.8B | $8.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.6B | $5.2B | $5.5B | $5.6B | $5.8B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $5.6B | $5.2B | $5.5B | $5.6B | $5.8B | |
| Operating Income | $3.4B | $4.9B | $4.4B | $3.2B | $2.9B | |
| Net Interest Expenses | $459.4M | $481.2M | $1.1B | $1.1B | $1.4B | |
| EBT. Incl. Unusual Items | $4.2B | $6.5B | $5.6B | $4.9B | $4.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4B | $1.9B | $1.7B | $1.4B | $1.4B | |
| Net Income to Company | $6B | $8.7B | $7.7B | $6.9B | $6.2B | |
| Minority Interest in Earnings | $190.4M | $216.1M | $143.3M | $83.8M | $170.4M | |
| Net Income to Common Excl Extra Items | $6B | $8.7B | $7.7B | $6.9B | $6.3B | |
| Basic EPS (Cont. Ops) | $1.76 | $2.64 | $2.47 | $2.27 | $2.11 | |
| Diluted EPS (Cont. Ops) | $1.76 | $2.64 | $2.47 | $2.27 | $2.11 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $6.1B | $7.2B | $6.4B | $5.2B | $5B | |
| EBIT | $3.4B | $4.9B | $4.4B | $3.2B | $2.9B | |
| Revenue (Reported) | $100B | $110.6B | $95.5B | $94.9B | $94.4B | |
| Operating Income (Reported) | $3.4B | $4.9B | $4.4B | $3.2B | $2.9B | |
| Operating Income (Adjusted) | $3.4B | $4.9B | $4.4B | $3.2B | $2.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $49.4B | $55.4B | $45.2B | $48B | $46.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.5B | $50.7B | $40.9B | $44B | $42.1B | |
| Gross Profit | $4.8B | $4.7B | $4.3B | $4B | $4.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5B | $2.4B | $2.8B | $2.9B | $2.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.5B | $2.4B | $2.8B | $2.9B | $2.9B | |
| Operating Income | $2.3B | $2.3B | $1.5B | $1.1B | $1.4B | |
| Net Interest Expenses | $235.4M | $294.4M | $570.6M | $548.7M | $643.9M | |
| EBT. Incl. Unusual Items | $3B | $3B | $2.5B | $1.8B | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $980.8M | $880.7M | $742M | $749.4M | |
| Net Income to Company | $3.8B | $4.2B | $3.3B | $2.7B | $3B | |
| Minority Interest in Earnings | $117.5M | $128.7M | $92.1M | $58.3M | $90M | |
| Net Income to Common Excl Extra Items | $3.8B | $4.2B | $3.3B | $2.7B | $3B | |
| Basic EPS (Cont. Ops) | $1.12 | $1.27 | $1.07 | $0.90 | $1.01 | |
| Diluted EPS (Cont. Ops) | $1.12 | $1.27 | $1.07 | $0.90 | $1.01 | |
| Weighted Average Basic Share | $6.6B | $6.3B | $6.1B | $5.9B | $5.7B | |
| Weighted Average Diluted Share | $6.6B | $6.3B | $6.1B | $5.9B | $2.9B | |
| EBITDA | $3.6B | $3.3B | $2.5B | $2.1B | $2.4B | |
| EBIT | $2.3B | $2.3B | $1.5B | $1.1B | $1.4B | |
| Revenue (Reported) | $49.4B | $55.4B | $45.2B | $48B | $46.3B | |
| Operating Income (Reported) | $2.3B | $2.3B | $1.5B | $1.1B | $1.4B | |
| Operating Income (Adjusted) | $2.3B | $2.3B | $1.5B | $1.1B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10B | $9.6B | $10.5B | $6B | $6.6B | |
| Short Term Investments | $3.9B | $8.2B | $5.8B | $7.5B | $6.3B | |
| Accounts Receivable, Net | $14.6B | $17.7B | $14.9B | $13.5B | $14B | |
| Inventory | $5.6B | $7.8B | $7.1B | $6.4B | $6.4B | |
| Prepaid Expenses | $1.3B | $1.5B | $1.7B | $2.4B | $2.9B | |
| Other Current Assets | $1.3B | $1.3B | $862.4M | $857.7M | $873.2M | |
| Total Current Assets | $38.1B | $47.1B | $42.6B | $38.1B | $38B | |
| Property Plant And Equipment | $19.7B | $18.1B | $17.3B | $15.9B | $16.5B | |
| Long-Term Investments | $51.8B | $53.9B | $51.7B | $52.7B | $52.9B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1B | $989.3M | $1.1B | $1.3B | $995.8M | |
| Total Assets | $113.3B | $123B | $115.6B | $111.7B | $112.4B | |
| Accounts Payable | $10.8B | $13.1B | $10B | $9.5B | $9.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $417.2M | $451.5M | $358.8M | $364.4M | $383M | |
| Total Current Liabilities | $24.4B | $31.4B | $28.3B | $25.7B | $24.4B | |
| Long-Term Debt | $36.2B | $34.5B | $28.5B | $25.2B | $27.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $69.6B | $75.2B | $66.2B | $60.3B | $60.5B | |
| Common Stock | $3.1B | $2.8B | $2.6B | $2.3B | $2.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $41.4B | $46.2B | $47.8B | $49.8B | $50.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.3B | $1.6B | $1.5B | $1.5B | $1.4B | |
| Total Equity | $43.6B | $47.7B | $49.3B | $51.3B | $51.9B | |
| Total Liabilities and Equity | $113.3B | $123B | $115.6B | $111.7B | $112.4B | |
| Cash and Short Terms | $10B | $9.6B | $10.5B | $6B | $6.6B | |
| Total Debt | $40.2B | $37.9B | $34.6B | $29.9B | $31.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.7B | $7.4B | $8B | $6B | $6.4B | |
| Short Term Investments | $7B | $8.8B | $6.4B | $6.3B | -- | |
| Accounts Receivable, Net | $16.9B | $16.7B | $14.9B | $15.3B | $13.7B | |
| Inventory | $6.6B | $7.1B | $6.1B | $6.7B | $6.8B | |
| Prepaid Expenses | $1.5B | $1.5B | $2.2B | $2.6B | $2.9B | |
| Other Current Assets | $1.3B | $1.1B | $1.2B | $977.8M | -- | |
| Total Current Assets | $41.1B | $42.5B | $38.8B | $38.3B | $38.6B | |
| Property Plant And Equipment | $18.5B | $16.2B | $16.3B | $16.8B | $17.9B | |
| Long-Term Investments | $52.7B | $48.3B | $51.7B | $53.7B | $55.9B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $906.5M | $867.9M | $1.1B | $1.2B | -- | |
| Total Assets | $116.1B | $110.8B | $111.5B | $113.9B | $117.8B | |
| Accounts Payable | $12.5B | $11.9B | $10.8B | $11.2B | $10.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $496.3M | $396M | $352M | $356.6M | -- | |
| Total Current Liabilities | $27.8B | $32B | $26.2B | $25.2B | $24B | |
| Long-Term Debt | $34.7B | $27.1B | $26.8B | $25.6B | $28.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $71.4B | $67.5B | $62.7B | $60.2B | $61.9B | |
| Common Stock | $3.1B | $2.4B | $2.3B | $2.4B | $2.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.3B | $1.5B | $1.5B | $1.5B | $1.6B | |
| Total Equity | $44.7B | $43.3B | $48.8B | $53.7B | $55.9B | |
| Total Liabilities and Equity | $116.1B | $110.8B | $111.5B | $113.9B | $117.8B | |
| Cash and Short Terms | $7.7B | $7.4B | $8B | $6B | $6.4B | |
| Total Debt | $39B | $33.8B | $30.8B | $29.9B | $31.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.3B | $8.3B | $8.5B | $7.5B | $6B | |
| Depreciation & Amoritzation | $2.6B | $2.6B | $2B | $2B | $2.1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$384.7M | -$3.7B | $1.6B | -$256.8M | -$667.2M | |
| Change in Inventories | -$321.7M | -$2.6B | $396.3M | $372.9M | $37.9M | |
| Cash From Operations | $7.3B | $7.2B | $7.7B | $6B | $6.7B | |
| Capital Expenditures | $2B | $1.7B | $1.7B | $2B | $2.3B | |
| Cash Acquisitions | $171.7M | $872.8M | $383.2M | $807.9M | $625.7M | |
| Cash From Investing | -$3.2B | -$2.5B | -$1.7B | -$3B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.3B | $1.5B | $1.7B | $1.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $8.1B | $10.7B | -- | $6B | $9.7B | |
| Long-Term Debt Repaid | -$9.8B | -$11.2B | -$1.6B | -$8.3B | -$8.8B | |
| Repurchase of Common Stock | $672.6M | $1.6B | $2B | $963M | $2.6B | |
| Other Financing Activities | -$171.8M | -$873.6M | -$384.6M | -$72.9M | -$197.7M | |
| Cash From Financing | -$4.4B | -$4.6B | -$4.3B | -$6.9B | -$4.7B | |
| Beginning Cash (CF) | $9.6B | $9.3B | $10.4B | $5.9B | $6.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $41.6M | $575.9M | $1.9B | -$3.4B | $519.2M | |
| Ending Cash (CF) | $10.1B | $10.3B | $12.6B | $3.1B | $6.9B | |
| Levered Free Cash Flow | $5.3B | $5.5B | $6B | $3.9B | $4.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.9B | $1.5B | $927.4M | $1.6B | |
| Depreciation & Amoritzation | $663.3M | $513.5M | $470.8M | $522.4M | $521.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$75.4M | $808.5M | -$546.7M | $736.9M | $665.8M | |
| Change in Inventories | -$216.2M | -$184.5M | $348.3M | -$158.4M | -$478.8M | |
| Cash From Operations | $1.2B | $212.8M | $689.4M | $2.1B | $1.1B | |
| Capital Expenditures | $406.6M | $395.8M | $542.4M | $461.9M | $623.4M | |
| Cash Acquisitions | $21.9M | $61.6M | -$35.1M | $5M | $10.6M | |
| Cash From Investing | -$532.8M | -$209M | -$661.3M | -$116.3M | -$475M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$20.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.7B | $1.8B | $1.2B | -- | -- | |
| Long-Term Debt Repaid | -$2.5B | -$2.7B | -$1.4B | -- | -- | |
| Repurchase of Common Stock | $295.5M | $355.1M | $190.7M | $824.9M | -- | |
| Other Financing Activities | -$21.4M | -$47.5M | $48M | -- | -- | |
| Cash From Financing | -$1.6B | -$1.2B | -$680.2M | -$2.8B | -$1.1B | |
| Beginning Cash (CF) | $7.7B | $7.4B | $8B | $6B | $6.4B | |
| Foreign Exchange Rate Adjustment | -$77.3M | $120M | $56.9M | -$383.9M | $114.8M | |
| Additions / Reductions | -$1B | -$1.1B | -$595.1M | -$1.2B | -$373.9M | |
| Ending Cash (CF) | $6.6B | $6.4B | $7.5B | $4.4B | $6.2B | |
| Levered Free Cash Flow | $754.8M | -$183.1M | $147.1M | $1.6B | $466.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6B | $8.7B | $7.7B | $6.9B | $6.2B | |
| Depreciation & Amoritzation | $2.7B | $2.3B | $2B | $2.1B | $2.1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$3.4B | -$2.6B | $1.3B | -$291.7M | $513.9M | |
| Change in Inventories | -$1.3B | -$1.6B | $987M | -$200.9M | -$260.7M | |
| Cash From Operations | $6.6B | $6.7B | $8.8B | $6.6B | $5.6B | |
| Capital Expenditures | $1.7B | $1.6B | $1.9B | $2.1B | $2.4B | |
| Cash Acquisitions | $228.9M | $1B | $799.6M | $458.5M | $583.6M | |
| Cash From Investing | -$2.6B | -$2.3B | -$2.6B | -$1.3B | -$2.6B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.4B | $1.6B | $1.7B | $1.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.4B | $10.2B | $688.5M | -- | -- | |
| Long-Term Debt Repaid | -$10.9B | -$10.1B | -$3.4B | -- | -- | |
| Repurchase of Common Stock | $1.2B | $1.3B | $1.9B | $1.7B | $1.3B | |
| Other Financing Activities | -$226.6M | -$1B | -$97.2M | -- | -- | |
| Cash From Financing | -$6.4B | -$3.5B | -$5.4B | -$7.6B | -$2.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.2B | $1.9B | $985.6M | -$2.3B | $617.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $4.9B | $5B | $6.9B | $4.5B | $3.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.8B | $4.2B | $3.3B | $2.7B | $3B | |
| Depreciation & Amoritzation | $1.3B | $1B | $974.8M | $1B | $1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$864.1M | $197.5M | -$108.1M | -$162.2M | $979.4M | |
| Change in Inventories | -$985.6M | $22.6M | $573.6M | -$15.9M | -$308.3M | |
| Cash From Operations | $2.8B | $2.4B | $3.4B | $3.9B | $2.9B | |
| Capital Expenditures | $831.4M | $813.3M | $1B | $1.1B | $1.2B | |
| Cash Acquisitions | $120.4M | $290M | $696.9M | $315.4M | $286.9M | |
| Cash From Investing | -$1.5B | -$1.3B | -$2.1B | -$351.5M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | $686.3M | $739.8M | $831.3M | $816.8M | $974.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.2B | $3.6B | $4.3B | -- | $2.9B | |
| Long-Term Debt Repaid | -$5.3B | -$4.1B | -$5.9B | -- | -$2.3B | |
| Repurchase of Common Stock | $978.5M | $748.2M | $639.2M | $1.3B | -- | |
| Other Financing Activities | -$119.8M | -$276.4M | $11M | -- | -$82.7M | |
| Cash From Financing | -$3.1B | -$2B | -$3.1B | -$3.7B | -$1.4B | |
| Beginning Cash (CF) | $16.5B | $16.3B | $16.9B | $12.4B | $13.4B | |
| Foreign Exchange Rate Adjustment | -$97.1M | $518.4M | $491.2M | -$168.3M | $73.5M | |
| Additions / Reductions | -$1.8B | -$399.7M | -$1.4B | -$313.1M | -$176.3M | |
| Ending Cash (CF) | $14.6B | $16.5B | $16B | $11.9B | $13.3B | |
| Levered Free Cash Flow | $2B | $1.6B | $2.4B | $2.8B | $1.7B | |
Signup to receive the latest stock alerts
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
With the market starting to look skittish on pure-play AI…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.